EMJ Oncology 10 [Supplement 7] . 2022

In this issue

EMJ had the pleasure of interviewing leading specialists in the field of breast cancer: Javier Cortés, International Breast Cancer Center, Quiron Group, Barcelona, Spain, and Giuseppe Curigliano, European Institute of Oncology (IEO), Instituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rionero in Vulture, and University of Milano, Milan, Italy. Both experts in the management of human epidermal growth factor receptor 2-positive metastatic breast cancer (HER2+ MBC), Cortés and Curigliano offered their perspectives on the current issues in the treatment of this disease.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?